跳至主要内容
临床试验/NCT01430377
NCT01430377Unknown4 期

Side Branch Predilatation Strategy in Coronary Bifurcation Lesion Stenting (SBPS)

Medica Cor Heart Hospital2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2011年8月1日最近更新:
适应症

试验速览

阶段
4 期
发起方
入组人数
120
试验地点
2
主要终点
Time for rewiring SB

研究概览

简要总结

The role of Side Branch (SB) predilatation during coronary bifurcation lesion percutaneous coronary intervention (PCI) is still not established. The predilatation could potentially damage SB ostium by vessel dissection, making subsequent wiring problematic. However, predilatation could eliminate SB ostial stenosis obviating need for further SB treatment after main vessel stent implantation. The aim of the study is to assess in random fashion the periprocedural myonecrosis, complication rates and time for SB rewiring in groups with and without SB predilatation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inclusion Criteria
  • Subject at least 18 years of age.
  • Subject able to verbally confirm understandings of risks, benefits of receiving PCI for true bifurcation lesions, and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
  • Target main branch lesion(s) located in a native coronary artery with diameter of ≥ 2.5 mm and ≤ 4.5 mm. Target side branch lesion(s) located in a native coronary artery with diameter of ≥ 2.0 mm.
  • Target lesion(s) amenable for PCI with balloon angioplasty of the side branch.

排除标准

  • ST-segment elevation myocardial infarction (STEMI)
  • Non-cardiac co-morbid conditions are present with life expectancy <1 year or that may result in protocol non-compliance (per site investigator's medical judgment).
  • Subjects who refuse to give informed consent.
  • Subjects with left ventricle ejection fraction <30%
  • Subjects with moderate or severe degree valvular heart disease or primary cardiomyopathy
  • Contraindications for 12 months double antiplatelet therapy

结局指标

主要结局

Time for rewiring SB

时间窗: 24h

次要结局

  • MACE(12 months)
  • Periprocedural myonecrosis(24 h)

研究者

发起方
Medica Cor Heart Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dobrin Vassilev MD, PhD

Dobrin Vassilev MD, PhD

Medica Cor Heart Hospital

研究点 (2)

Loading locations...

相似试验